Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
ACS Appl Bio Mater ; 4(6): 4789-4799, 2021 06 21.
Article in English | MEDLINE | ID: mdl-35007028

ABSTRACT

Hepatocellular carcinoma (HCC) is the sixth most common neoplasia and the fourth most common cause of cancer-related mortality worldwide. Sorafenib is the first-line molecular therapy for patients in an advanced stage of HCC. However, the recommended clinical dose of Sorafenib is associated with several complications, which derive from its lack of cell specificity and its very low water solubility. To circumvent these drawbacks, in the present study we developed two sugar-coated polydiacetylene-based nanomicelles-Sorafenib carriers targeting mannose and asialoglycoprotein receptors (MR and ASGPR, respectively). The strategies allowed the inducement of apoptosis and reduction of cell proliferation at a nanomolar, instead of micromolar, range in liver cancer cells. The study showed that, contrary to literature data, Sorafenib included into the pMicMan (Man = mannose) vector (targeting MR) is more efficient than pMicGal (Gal = galactose) (targeting ASGPR). Indeed, pMicMan increased the endosomal incorporation with an increased intracellular Sorafenib concentration that induced apoptosis and reduced cell proliferation at a low concentration range (10-20 nM).


Subject(s)
Antineoplastic Agents/administration & dosage , Carcinoma, Hepatocellular/drug therapy , Galactose/administration & dosage , Liver Neoplasms/drug therapy , Mannose/administration & dosage , Nanoparticles/administration & dosage , Polyacetylene Polymer/administration & dosage , Sorafenib/administration & dosage , Antineoplastic Agents/chemistry , Apoptosis/drug effects , Asialoglycoprotein Receptor/metabolism , Carcinoma, Hepatocellular/metabolism , Cell Proliferation/drug effects , Endosomes/metabolism , Galactose/chemistry , Hep G2 Cells , Humans , Liver Neoplasms/metabolism , Mannose/chemistry , Mannose Receptor/metabolism , Micelles , Nanoparticles/chemistry , Polyacetylene Polymer/chemistry , Sorafenib/chemistry
2.
Int J Pharm ; 565: 59-63, 2019 Jun 30.
Article in English | MEDLINE | ID: mdl-31029658

ABSTRACT

In this study, a "click and hybridization" strategy was developed for the functionalization of polydiacetylene micelles with a targeting aptamer ligand. Decoration of the nanocarriers with an anti-Annexin A2 sequence efficiently triggered enhanced internalization of the functionalized micelles in the MCF-7 cell line, with a marked increase compared to control micelles.


Subject(s)
Annexin A2/genetics , Aptamers, Nucleotide/administration & dosage , Drug Carriers/administration & dosage , Micelles , Polyacetylene Polymer/administration & dosage , Biological Transport , Humans , MCF-7 Cells
3.
Nanotechnology ; 30(24): 245101, 2019 Jun 14.
Article in English | MEDLINE | ID: mdl-30836350

ABSTRACT

Polydiacetylene-based nanoparticles have been developed as nanocarriers for various bio-applications. However, how nanocarriers enter the cell environment and affect cell viability has not yet been considerably explored. In this study, polydiacetylene-based nanoliposomes (nanosomes) were electrostatically complexed with rhodamine fluorophores. Based on real-time cell imaging and cell viability assessment, the most highly polymerized nanosomes were found to be less toxic to cells. Moreover, it was revealed that the rhodamine/polydiacetylene nanosome complex dissociates at cell environment, the polydiacetylene nanosome penetrates into cells, as suggested by the fluorescence observed in confocal microscopy images.


Subject(s)
Cell Survival/drug effects , Endocytosis/drug effects , Nanoparticles/administration & dosage , Polyacetylene Polymer/administration & dosage , Cell Line, Tumor , Humans , Liposomes/administration & dosage , Liposomes/chemistry , Nanoparticles/chemistry , Polyacetylene Polymer/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL
...